Dr Stephen Wren

About

I am highly experienced in medicinal chemistry and have worked on a diverse set of biological targets over many disease areas in several organisations (Xenova, Argenta Discovery and Summit plc). I have an extensive track record in project and team management, intellectual property, drug discovery in many therapeutic areas and helped lead the chemistry effort directed towards the identification of SMTC1100 (Summit's Duchenne Muscular Dystrophy drug, currently undergoing clinical evaluation).

I have also conducted research at the Alzheimer's Research UK Oxford Drug Discovery Institute and taught at Oxford University (organic chemistry, pharmaceutical chemistry and biomedical sciences). I was a fellow of St Hilda's College, Oxford, between 2015 and 2018.